Previous Article | Next Article 
Journal of Clinical Microbiology, January 2008, p. 350-351, Vol. 46, No. 1
0095-1137/08/$08.00+0 doi:10.1128/JCM.02130-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Comparison of BD GeneOhm Methicillin-Resistant Staphylococcus aureus (MRSA) PCR versus the CHROMagar MRSA Assay for Screening Patients for the Presence of MRSA Strains
John M. Boyce1,2* and
Nancy L. Havill1
Department of Medicine, Hospital of Saint Raphael, 1450 Chapel Street, New Haven, Connecticut 06511,1
Yale University School of Medicine, New Haven, Connecticut2
Received 3 November 2007/
Accepted 5 November 2007

ABSTRACT
We compared the BD GeneOhm methicillin-resistant
Staphylococcus aureus (MRSA) real-time PCR assay with the CHROMagar MRSA assay
for the detection of MRSA in 286 nasal surveillance specimens.
Compared with the CHROMagar MRSA assay, PCR had sensitivity,
specificity, positive predictive value, and negative predictive
values of 100%, 98.6%, 95.8%, and 100%, respectively. The mean
PCR turnaround time was 14.5 h.

TEXT
To rapidly detect methicillin-resistant
Staphylococcus aureus (MRSA) nasal colonization in patients, clinical microbiology
laboratories must choose between PCR methods and selective-agar-based
methods. Several chromogenic and differential MRSA selective
agars have been shown to yield results within 18 to 24 h (
4,
5,
7,
8,
11,
13). In contrast, PCR methods can yield results
in 2 to 3 hours. We compared the CHROMagar MRSA (C-MRSA) agar
assay (BD Diagnostics, Sparks, MD) with the BD GeneOhm MRSA
real-time PCR system (BD Diagnostics, Sparks, MD), formerly
called IDI-MRSA, which has been found to be a sensitive and
specific method for the detection of MRSA (
1,
2,
3,
6,
8,
9,
10,
14,
15,
16).
The study was conducted at a 450-bed, university-affiliated teaching hospital. Nasal swab specimens were obtained from 286 patients admitted to the surgical and medical intensive care units and a hematology-oncology ward.
Using a single Starswab II (Starplex Scientific, Inc., Canada), one nares specimen per patient was inoculated onto C-MRSA agar between 6 a.m. and 11 p.m., and the swab was refrigerated until PCR assays were run. C-MRSA plates were incubated at 36°C overnight and examined for the presence of mauve-colored colonies, both at the beginning and at the end of the day shift. Mauve-colored colonies with typical colony morphology and a positive Staphaurex (Remel, Lenexa, KS) coagulase test were classified as MRSA (5). Negative C-MRSA plates were incubated for an additional 24 h and reexamined for the presence of MRSA at the beginning of the next day shift.
The PCR assay was performed once daily, following the manufacturer's recommendations. Brain heart infusion broth (BD Diagnostics, Sparks, MD) was added to all PCR-positive broths, and the broths were incubated overnight and subcultured onto C-MRSA agar to evaluate the performance of the PCR assay. Testing of unresolved specimens was repeated, following the manufacturer's recommended freeze-thaw procedure. A "false-positive" PCR result was defined as a positive PCR assay performed on a nasal swab that yielded no growth of MRSA on C-MRSA agar and the failure of MRSA to grow from broth subculture of the PCR tube. Turnaround times were recorded prospectively for both the C-MRSA and the PCR assay.
Dichotomous variables were compared by using McNemar's test. Continuous variables were compared by using a paired-sample t test or Wilcoxon test (SSPS, Chicago, IL).
A total of 286 nasal swab specimens were tested by using the C-MRSA and PCR assays. Sixty-three (22%) specimens were positive for MRSA on C-MRSA agar. In contrast, 72 (25.2%) were positive for MRSA by the PCR method. Sixty-nine (24.1%) were considered true-positive results and three (1%) were classified as false-positive results by the PCR method. Another three specimens were initially unresolved by PCR, but were negative after repeat testing using the freeze-thaw procedure. After excluding the three false-positive results from the analysis, the 9.5%-higher yield obtained by the PCR method was statistically significant (McNemar's test; P = 0.04) All six of the specimens positive by PCR but negative on C-MRSA agar were newly identified MRSA carriers, none of whom had subsequent clinical cultures positive for MRSA. Compared to the C-MRSA agar assay, the PCR method had a sensitivity of 100%, specificity of 98.6%, positive predictive value of 95.8%, and negative predictive value of 100%.
The mean and median turnaround times for the PCR assay were significantly shorter than those for the C-MRSA agar assay (Table 1). The cost for a negative culture on C-MRSA agar was $6.71 versus $7.52 for a positive culture with a confirmatory coagulase test. Technician time was 1.5 min for negative cultures and 2 min for positive cultures. The cost per test for PCR assays was $25.50, and technician time varied from 5 to 9 min.
We found that 53/63 (84%) specimens positive for MRSA on C-MRSA
agar were detected within 24 h, a finding similar to that reported
by Flayhart et al. (
5). The advantages of C-MRSA agar over nonselective
agars include the short incubation time required to detect MRSA,
the minimal technician time required for reading plates, and
the lack of the need for susceptibility tests.
The PCR method was significantly more sensitive than the C-MRSA agar assay, detecting 9.5% more patients colonized with MRSA. Exact comparison of the PCR performance results in the present study to those observed in other studies of the BD GeneOhm MRSA PCR assay is problematic, since we used the C-MRSA agar formulation distributed by BD Diagnostics, whereas previous studies used other chromogenic media or nonchromogenic selective media (1, 2, 8, 10, 12, 14, 16). In the present study, the PCR assay had a sensitivity of 100%, slightly higher than that reported in other studies in which nasal swab specimens were directly inoculated onto agar (range, 90% to 98.5%) (1, 8, 10, 14-16) and similar to (100%) or greater than in four other studies in which agar-based cultures included a broth enrichment step (range, 81% to 92%) (1, 2, 9, 12, 15). While broth enrichment cultures have the advantage of increasing sensitivity by as much as 2% to 23% (1, 12, 15), they require more technician time and an additional one to three days before results are available (2, 3).
Batch-processing of PCR assays once daily in the present study yielded average turnaround times of 13 h for PCR-positive specimens and 15 h for PCR-negative specimens, which compares favorably with the average turnaround time of 19 h reported by others (2).
Our study has several limitations. Since we did not use nonselective agar, we were unable to determine if the few false-positive results yielded by PCR were due to methicillin-susceptible S. aureus isolates with a residual SCCmec right-extremity fragment following the deletion of a chromosomal segment containing mecA (6). Omitting the use of enrichment broth and inoculating only selective-agar medium for the growth of MRSA may have slightly overestimated the sensitivity of the PCR method.
In conclusion, C-MRSA agar detects a majority of cases of MRSA nasal colonization in patients in less than 24 h and is easy to use. Compared to C-MRSA agar, the BD GeneOhm MRSA PCR assay was more sensitive, provided significantly faster turnaround times, and resulted in more-prompt isolation of MRSA-colonized patients. Further studies are warranted to determine if the greater costs of PCR assays are offset by cost savings from reduced transmission of MRSA.

ACKNOWLEDGMENTS
J. M. Boyce has received speaker honoraria from BD GeneOhm.

FOOTNOTES
* Corresponding author. Mailing address: Infectious Diseases Section, Hospital of Saint Raphael, 1450 Chapel Street, New Haven, CT 06511. Phone: (203) 789-3566. Fax: (203) 789-4239. E-mail:
JBoyce{at}srhs.org 
Published ahead of print on 21 November 2007. 

REFERENCES
1 - Bishop, E. J., E. A. Grabsch, S. A. Ballard, B. Mayall, S. Xie, R. Martin, and M. L. Grayson. 2006. Concurrent analysis of nose and groin swab specimens by the IDI-MRSA PCR assay is comparable to analysis by individual-specimen PCR and routine culture assays for detection of colonization by methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 44:2904-2908.[Abstract/Free Full Text]
2 - de San, N., O. Denis, M.-F. Gasasira, R. De Mendonca, C. Nonhoff, and M. J. Struelens. 2007. Controlled evaluation of the IDI-MRSA assay for detection of colonization by methicillin-resistant Staphylococcus aureus in diverse mucocutaneous specimens. J. Clin. Microbiol. 45:1098-1101.[Abstract/Free Full Text]
3 - Desjardins, M., C. Guibord, B. Lalonde, B. Toye, and K. Ramotar. 2006. Evaluation of the IDI-MRSA assay for detection of methicillin-resistant Staphylococcus aureus from nasal and rectal specimens pooled in a selective broth. J. Clin. Microbiol. 44:1219-1223.[Abstract/Free Full Text]
4 - Diederen, B., I. van Duijn, A. van Belkum, P. Willemse, P. van Keulen, and J. Kluytmans. 2005. Performance of CHROMagar MRSA medium for detection of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 43:1925-1927.[Abstract/Free Full Text]
5 - Flayhart, D., J. F. Hindler, D. A. Bruckner, G. Hall, R. K. Shrestha, S. A. Vogel, S. S. Richter, W. Howard, R. Walther, and K. C. Carroll. 2005. Multicenter evaluation of BBL CHROMagar MRSA medium for direct detection of methicillin-resistant Staphylococcus aureus from surveillance cultures of the anterior nares. J. Clin. Microbiol. 43:5536-5540.[Abstract/Free Full Text]
6 - Huletsky, A., R. Giroux, V. Rossbach, M. Gagnon, M. Vaillancourt, M. Bernier, F. Gagnon, K. Truchon, M. Bastien, F. J. Picard, A. van Belkum, M. Oullette, P. H. Roy, and M. G. Bergeron. 2004. New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. J. Clin. Microbiol. 42:1875-1884.[Abstract/Free Full Text]
7 - Nahimana, I., P. Francioli, and D. S. Blanc. 2006. Evaluation of three chromogenic media (MRSA-ID, MRSA-Select and CHROMagar MRSA) and ORSAB for surveillance cultures of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 12:1168-1174.[CrossRef][Medline]
8 - Nguyen Van, J. C., M. D. Kitzis, A. Ly, A. Chalfine, J. Carlet, A. Ben Ali, and F. Goldstein. 2006. Detection of nasal colonization methicillin-resistant Staphylococcus aureus: a prospective study comparing real-time genic amplification assay vs selective chromogenic media. Pathol. Biol. 54:285-292.[CrossRef][Medline]
9 - Oberdorfer, K., S. Pohl, M. Heeg, and C. Wendt. 2006. Evaluation of a single-locus real-time polymerase chain reaction as a screening test for specific detection of methicillin-resistant Staphylococcus aureus in ICU patients. Eur. J. Clin. Microbiol. Infect. Dis. 25:657-663.[CrossRef][Medline]
10 - Paule, S. M., D. M. Hacek, B. Kufner, K. Truchon, R. B. Thomson, Jr., K. L. Kaul, A. Robicsek, and L. R. Peterson. 2007. Performance of the BD GeneOhm methicillin-resistant Staphylococcus aureus test before and during high-volume clinical use. J. Clin. Microbiol. 45:2993-2998.[Abstract/Free Full Text]
11 - Perry, J. D., A. Davies, L. A. Butterworth, A. L. J. Hopley, A. Nicholson, and F. K. Gould. 2004. Development and evaluation of a chromogenic agar medium for methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 42:4519-4523.[Abstract/Free Full Text]
12 - Rossney, A. S., C. M. Herra, M. M. Fitzgibbon, P. M. Morgan, M. J. Lawrence, and B. O'Connell. 2007. Evaluation of the IDI-MRSA assay on the SmartCycler real-time PCR platform for rapid detection of MRSA from screening specimens. Eur. J. Clin. Microbiol. Infect. Dis. 26:459-466.[CrossRef][Medline]
13 - Stoakes, L., R. Reyes, J. Daniel, G. Lennox, M. A. John, R. Lannigan, and Z. Hussain. 2006. Prospective comparison of a new chromogenic media, MRSASelect, to CHROMagar MRSA and mannitol-salt medium supplemented with oxacillin or cefoxitin for detection of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 44:637-639.[Abstract/Free Full Text]
14 - van Hal, S. J., D. Stark, B. Lockwood, D. Marriott, and J. Harkness. 2007. Methicillin-resistant Staphylococcus aureus (MRSA) detection: comparison of two molecular methods (IDI-MRSA PCR assay and GenoType MRSA Direct PCR assay) with three selective MRSA agars (MRSA ID, MRSASelect, and CHROMagar MRSA) for use with infection control swabs. J. Clin. Microbiol. 45:2486-2490.[Abstract/Free Full Text]
15 - Warren, D. K., R. S. Liao, L. R. Merz, M. Eveland, and W. M. J. Dunne. 2004. Detection of methicillin-resistant Staphylococcus aureus directly from nasal swab specimens by a real-time PCR assay. J. Clin. Microbiol. 42:5578-5581.[Abstract/Free Full Text]
16 - Wren, M. W. D., C. Carder, P. G. Coen, V. Gant, and A. P. R. Wilson. 2006. Rapid molecular detection of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 44:1604.[Free Full Text]
Journal of Clinical Microbiology, January 2008, p. 350-351, Vol. 46, No. 1
0095-1137/08/$08.00+0 doi:10.1128/JCM.02130-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Bischof, L. J., Lapsley, L., Fontecchio, K., Jacosalem, D., Young, C., Hankerd, R., Newton, D. W.
(2009). Comparison of Chromogenic Media to BD GeneOhm Methicillin-Resistant Staphylococcus aureus (MRSA) PCR for Detection of MRSA in Nasal Swabs. J. Clin. Microbiol.
47: 2281-2283
[Abstract]
[Full Text]
-
Munson, E., Block, T., Voegeli, J. T., Hryciuk, J. E., Schell, R. F.
(2009). Cost-Effective Frozen Master Mix Modification of a Commercial Methicillin-Resistant Staphylococcus aureus PCR Assay. J. Clin. Microbiol.
47: 1888-1891
[Abstract]
[Full Text]
-
Bartels, M. D., Boye, K., Rohde, S. M., Larsen, A. R., Torfs, H., Bouchy, P., Skov, R., Westh, H.
(2009). A Common Variant of Staphylococcal Cassette Chromosome mec Type IVa in Isolates from Copenhagen, Denmark, Is Not Detected by the BD GeneOhm Methicillin-Resistant Staphylococcus aureus Assay. J. Clin. Microbiol.
47: 1524-1527
[Abstract]
[Full Text]
-
Paule, S. M., Mehta, M., Hacek, D. M., Gonzalzles, T.-M., Robicsek, A., Peterson, L. R.
(2009). Chromogenic Media vs Real-Time PCR for Nasal Surveillance of Methicillin-Resistant Staphylococcus aureus: Impact on Detection of MRSA-Positive Persons. Am J Clin Pathol
131: 532-539
[Abstract]
[Full Text]
-
Wolk, D. M., Picton, E., Johnson, D., Davis, T., Pancholi, P., Ginocchio, C. C., Finegold, S., Welch, D. F., de Boer, M., Fuller, D., Solomon, M. C., Rogers, B., Mehta, M. S., Peterson, L. R.
(2009). Multicenter Evaluation of the Cepheid Xpert Methicillin-Resistant Staphylococcus aureus (MRSA) Test as a Rapid Screening Method for Detection of MRSA in Nares. J. Clin. Microbiol.
47: 758-764
[Abstract]
[Full Text]
-
Podzorski, R. P., Li, H., Han, J., Tang, Y.-W.
(2008). MVPlex Assay for Direct Detection of Methicillin-Resistant Staphylococcus aureus in Naris and Other Swab Specimens. J. Clin. Microbiol.
46: 3107-3109
[Abstract]
[Full Text]